US FEDERAL PATENTS ON CBD AND CANCER

 We are all sort of still shocked by knowing that molecular CBD was initially patented by the US Federal Government in October 2003. They licensed/license it to pharmaceutical companies. I THINK they recently sold the patent.

Anyway, I saw a patient the other day with multiple meningioma brain tumors. They are not “cancerous”, but their growth in the middle of the brain makes them a real clinical challenge. They asked me if I had any experience with these “benign” meningiomas; I had not. So, I looked it up and found two US Federal Patents using CBD for treatment of Meningiomas.

I imagine the US Government felt it was worth spending the money on the patent and must feel it has real value? Right? Why else patent CBD for more and more diseases?

Personally, I take this as an endorsement of the work we are doing. 

References:

http://www.google.com/patents/US8632825

https://www.google.com/search?tbm=pts&hl=en&q=us+patent+20080262099&gws_rd=ssl

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.